SEC Filing Details
Document Details
Form
Filing Date
January 28, 2021
Document Date
January 19, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
ATTIE KENNETH